Skip to main content
Premium Trial:

Request an Annual Quote

Lynx Will Study Algae for Woods Hole Oceanographic Institution

NEW YORK, Dec. 19-Lynx Therapeutics said today that it has a service agreement with the Woods Hole Oceanographic Institution to study gene expression in a marine dinoflagellate that causes red tides.


Lynx will receive payments from the institute to use its Massively Parallel Signature Sequencing technology on samples of Alexandrium fundyense, an algae that can cause paralytic shellfish poisoning in people who eat contaminated shellfish.


The company's platform will be used to study the physiology of algal bloom formation and the production of neurotoxins, with the aim of creating new ways to monitor shellfish.


Financial details of the agreement were not revealed. Yesterday, Lynx also announced that it has received a delisting noticefrom Nasdaq; the company plans to appeal the notice.

The Scan

Driving Malaria-Carrying Mosquitoes Down

Researchers from the UK and Italy have tested a gene drive for mosquitoes to limit the spread of malaria, NPR reports.

Office Space to Lab Space

The New York Times writes that some empty office spaces are transforming into lab spaces.

Prion Pause to Investigate

Science reports that a moratorium on prion research has been imposed at French public research institutions.

Genome Research Papers on Gut Microbe Antibiotic Response, Single-Cell RNA-Seq Clues to Metabolism, More

In Genome Research this week: gut microbial response to antibiotic treatment, approach to gauge metabolic features from single-cell RNA sequencing, and more.